Clinical manifestations and outcome of pseudomembranous colitis in an elderly population in Israel

Pseudomembranous colitis is a well-recognized cause of diarrhea in patients receiving antibiotics and has significant consequences in terms of morbidity, mortality and cost. Clostridium difficile infection is the single most important infectious cause of PMC. PMC is frequently nosocomial, with an in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Israel Medical Association journal 2004-04, Vol.6 (4), p.201-204
Hauptverfasser: Moshkowitz, Menachem, Baruch, Efrat Ben, Kline, Zeev, Gelber, Moshe, Shimoni, Zvi, Konikoff, Fred
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 204
container_issue 4
container_start_page 201
container_title The Israel Medical Association journal
container_volume 6
creator Moshkowitz, Menachem
Baruch, Efrat Ben
Kline, Zeev
Gelber, Moshe
Shimoni, Zvi
Konikoff, Fred
description Pseudomembranous colitis is a well-recognized cause of diarrhea in patients receiving antibiotics and has significant consequences in terms of morbidity, mortality and cost. Clostridium difficile infection is the single most important infectious cause of PMC. PMC is frequently nosocomial, with an increased risk of spread among institutionalized patients, both in hospitals and nursing homes. To investigate the demographic, clinical and laboratory characteristics of PMC patients in an Israeli elderly population. We studied 72 hospitalized patients with endoscopically proven PMC. The medical records of all patients including clinical history and laboratory data were reviewed, such as: age, pre-hospitalization status (dependency or not, in the community as compared to the nursing home), background medical history, presenting symptoms, antibiotic history, physical examination on admission, hematologic and biochemical parameters, treatment, duration of hospitalization, complications, mortality, and recurrence of disease. Of the 72 patients (34 males and 38 females, mean age 77 years) 47% were nursing home residents. Pre-hospitalization antibiotic treatment was given to 91.4% for infections of the upper respiratory tract (45%) and urinary tract (45%). The most common antibiotics were cephalosporin (64%), penicillins (42%) and quinolones (28%). Sixty-four percent of the patients were treated with more than one antibiotic, 26% of patients received anti-acid therapy and 36% had been fed with a nasogastric tube. On admission, leukocytosis was found in 79% of patients, > 20,000/mm3 in half of them; 60% were anemic, 60% had elevated erythrocyte sedimentation rate, and 78% had hypoalbuminemia. Treatment consisted of metronidazole (41%) or a combination of metronidazole and vancomycin (56%). Overall, 31% of patients recovered without complications, 29% died within 30 days of hospitalization, and 24% were re-hospitalized due to recurrence of PMC. The most common antibiotics implicated in PMC are cephalosporin, penicillins and quinolones. The disease is associated with high mortality and recurrence rates.
format Article
fullrecord <record><control><sourceid>pubmed_igdc_</sourceid><recordid>TN_cdi_pubmed_primary_15115256</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15115256</sourcerecordid><originalsourceid>FETCH-LOGICAL-i229t-5ae13d5a6ad3c9981d38a05d2f7ac5fb2850c0165925f1de41439136223659063</originalsourceid><addsrcrecordid>eNo1j8tOwzAURL0A0VL4BJB_IJIfvSZZoopHpUpsYB3d-FEucuwoThb9ewKF1YxmjkaaC7aWYKCSoq5X7LqULyEUgGiu2EqClKDArFm3i5TIYuQ9Jgq-TDhRToVjcjzPk8295znwofjZLb7vRkx5LtzmSBMVTmlBuY_Oj_HEhzzM8Xfhp9iXEX28YZcBY_G3f7phH89P77vX6vD2st89HipSqpkqQC-1AzTotG2aWjpdowCnwgNaCJ2qQVghDTQKgnR-K7e6kdoopZdMGL1h9-fdYe5679phpB7HU_t_dgHuzgAdnW076iLl44jDJ9lWQa2_AVBOWtg</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Clinical manifestations and outcome of pseudomembranous colitis in an elderly population in Israel</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Moshkowitz, Menachem ; Baruch, Efrat Ben ; Kline, Zeev ; Gelber, Moshe ; Shimoni, Zvi ; Konikoff, Fred</creator><creatorcontrib>Moshkowitz, Menachem ; Baruch, Efrat Ben ; Kline, Zeev ; Gelber, Moshe ; Shimoni, Zvi ; Konikoff, Fred</creatorcontrib><description>Pseudomembranous colitis is a well-recognized cause of diarrhea in patients receiving antibiotics and has significant consequences in terms of morbidity, mortality and cost. Clostridium difficile infection is the single most important infectious cause of PMC. PMC is frequently nosocomial, with an increased risk of spread among institutionalized patients, both in hospitals and nursing homes. To investigate the demographic, clinical and laboratory characteristics of PMC patients in an Israeli elderly population. We studied 72 hospitalized patients with endoscopically proven PMC. The medical records of all patients including clinical history and laboratory data were reviewed, such as: age, pre-hospitalization status (dependency or not, in the community as compared to the nursing home), background medical history, presenting symptoms, antibiotic history, physical examination on admission, hematologic and biochemical parameters, treatment, duration of hospitalization, complications, mortality, and recurrence of disease. Of the 72 patients (34 males and 38 females, mean age 77 years) 47% were nursing home residents. Pre-hospitalization antibiotic treatment was given to 91.4% for infections of the upper respiratory tract (45%) and urinary tract (45%). The most common antibiotics were cephalosporin (64%), penicillins (42%) and quinolones (28%). Sixty-four percent of the patients were treated with more than one antibiotic, 26% of patients received anti-acid therapy and 36% had been fed with a nasogastric tube. On admission, leukocytosis was found in 79% of patients, &gt; 20,000/mm3 in half of them; 60% were anemic, 60% had elevated erythrocyte sedimentation rate, and 78% had hypoalbuminemia. Treatment consisted of metronidazole (41%) or a combination of metronidazole and vancomycin (56%). Overall, 31% of patients recovered without complications, 29% died within 30 days of hospitalization, and 24% were re-hospitalized due to recurrence of PMC. The most common antibiotics implicated in PMC are cephalosporin, penicillins and quinolones. The disease is associated with high mortality and recurrence rates.</description><identifier>ISSN: 1565-1088</identifier><identifier>PMID: 15115256</identifier><language>eng</language><publisher>Israel</publisher><subject>Adult ; Aged ; Anti-Bacterial Agents - adverse effects ; Enterocolitis, Pseudomembranous - chemically induced ; Enterocolitis, Pseudomembranous - diagnosis ; Enterocolitis, Pseudomembranous - drug therapy ; Female ; Humans ; Male ; Metronidazole - therapeutic use ; Middle Aged ; Retrospective Studies</subject><ispartof>The Israel Medical Association journal, 2004-04, Vol.6 (4), p.201-204</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786</link.rule.ids><backlink>$$Uhttp://igdc.huji.ac.il/home/Maagar/Details.aspx?AN=258$$D View record in IGDC$$Hfree_for_read</backlink><backlink>$$Uhttp://www.ima.org.il/FilesUpload/IMAJ/0/51/25995.pdf$$D View full text (Access may be restricted)$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15115256$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moshkowitz, Menachem</creatorcontrib><creatorcontrib>Baruch, Efrat Ben</creatorcontrib><creatorcontrib>Kline, Zeev</creatorcontrib><creatorcontrib>Gelber, Moshe</creatorcontrib><creatorcontrib>Shimoni, Zvi</creatorcontrib><creatorcontrib>Konikoff, Fred</creatorcontrib><title>Clinical manifestations and outcome of pseudomembranous colitis in an elderly population in Israel</title><title>The Israel Medical Association journal</title><addtitle>Isr Med Assoc J</addtitle><description>Pseudomembranous colitis is a well-recognized cause of diarrhea in patients receiving antibiotics and has significant consequences in terms of morbidity, mortality and cost. Clostridium difficile infection is the single most important infectious cause of PMC. PMC is frequently nosocomial, with an increased risk of spread among institutionalized patients, both in hospitals and nursing homes. To investigate the demographic, clinical and laboratory characteristics of PMC patients in an Israeli elderly population. We studied 72 hospitalized patients with endoscopically proven PMC. The medical records of all patients including clinical history and laboratory data were reviewed, such as: age, pre-hospitalization status (dependency or not, in the community as compared to the nursing home), background medical history, presenting symptoms, antibiotic history, physical examination on admission, hematologic and biochemical parameters, treatment, duration of hospitalization, complications, mortality, and recurrence of disease. Of the 72 patients (34 males and 38 females, mean age 77 years) 47% were nursing home residents. Pre-hospitalization antibiotic treatment was given to 91.4% for infections of the upper respiratory tract (45%) and urinary tract (45%). The most common antibiotics were cephalosporin (64%), penicillins (42%) and quinolones (28%). Sixty-four percent of the patients were treated with more than one antibiotic, 26% of patients received anti-acid therapy and 36% had been fed with a nasogastric tube. On admission, leukocytosis was found in 79% of patients, &gt; 20,000/mm3 in half of them; 60% were anemic, 60% had elevated erythrocyte sedimentation rate, and 78% had hypoalbuminemia. Treatment consisted of metronidazole (41%) or a combination of metronidazole and vancomycin (56%). Overall, 31% of patients recovered without complications, 29% died within 30 days of hospitalization, and 24% were re-hospitalized due to recurrence of PMC. The most common antibiotics implicated in PMC are cephalosporin, penicillins and quinolones. The disease is associated with high mortality and recurrence rates.</description><subject>Adult</subject><subject>Aged</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Enterocolitis, Pseudomembranous - chemically induced</subject><subject>Enterocolitis, Pseudomembranous - diagnosis</subject><subject>Enterocolitis, Pseudomembranous - drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Metronidazole - therapeutic use</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><issn>1565-1088</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j8tOwzAURL0A0VL4BJB_IJIfvSZZoopHpUpsYB3d-FEucuwoThb9ewKF1YxmjkaaC7aWYKCSoq5X7LqULyEUgGiu2EqClKDArFm3i5TIYuQ9Jgq-TDhRToVjcjzPk8295znwofjZLb7vRkx5LtzmSBMVTmlBuY_Oj_HEhzzM8Xfhp9iXEX28YZcBY_G3f7phH89P77vX6vD2st89HipSqpkqQC-1AzTotG2aWjpdowCnwgNaCJ2qQVghDTQKgnR-K7e6kdoopZdMGL1h9-fdYe5679phpB7HU_t_dgHuzgAdnW076iLl44jDJ9lWQa2_AVBOWtg</recordid><startdate>20040401</startdate><enddate>20040401</enddate><creator>Moshkowitz, Menachem</creator><creator>Baruch, Efrat Ben</creator><creator>Kline, Zeev</creator><creator>Gelber, Moshe</creator><creator>Shimoni, Zvi</creator><creator>Konikoff, Fred</creator><scope>AGDVQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20040401</creationdate><title>Clinical manifestations and outcome of pseudomembranous colitis in an elderly population in Israel</title><author>Moshkowitz, Menachem ; Baruch, Efrat Ben ; Kline, Zeev ; Gelber, Moshe ; Shimoni, Zvi ; Konikoff, Fred</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i229t-5ae13d5a6ad3c9981d38a05d2f7ac5fb2850c0165925f1de41439136223659063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Enterocolitis, Pseudomembranous - chemically induced</topic><topic>Enterocolitis, Pseudomembranous - diagnosis</topic><topic>Enterocolitis, Pseudomembranous - drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Metronidazole - therapeutic use</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moshkowitz, Menachem</creatorcontrib><creatorcontrib>Baruch, Efrat Ben</creatorcontrib><creatorcontrib>Kline, Zeev</creatorcontrib><creatorcontrib>Gelber, Moshe</creatorcontrib><creatorcontrib>Shimoni, Zvi</creatorcontrib><creatorcontrib>Konikoff, Fred</creatorcontrib><collection>IGDC Bibliographic Database - מאגר לחקר ההזדקנות</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>The Israel Medical Association journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moshkowitz, Menachem</au><au>Baruch, Efrat Ben</au><au>Kline, Zeev</au><au>Gelber, Moshe</au><au>Shimoni, Zvi</au><au>Konikoff, Fred</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical manifestations and outcome of pseudomembranous colitis in an elderly population in Israel</atitle><jtitle>The Israel Medical Association journal</jtitle><addtitle>Isr Med Assoc J</addtitle><date>2004-04-01</date><risdate>2004</risdate><volume>6</volume><issue>4</issue><spage>201</spage><epage>204</epage><pages>201-204</pages><issn>1565-1088</issn><abstract>Pseudomembranous colitis is a well-recognized cause of diarrhea in patients receiving antibiotics and has significant consequences in terms of morbidity, mortality and cost. Clostridium difficile infection is the single most important infectious cause of PMC. PMC is frequently nosocomial, with an increased risk of spread among institutionalized patients, both in hospitals and nursing homes. To investigate the demographic, clinical and laboratory characteristics of PMC patients in an Israeli elderly population. We studied 72 hospitalized patients with endoscopically proven PMC. The medical records of all patients including clinical history and laboratory data were reviewed, such as: age, pre-hospitalization status (dependency or not, in the community as compared to the nursing home), background medical history, presenting symptoms, antibiotic history, physical examination on admission, hematologic and biochemical parameters, treatment, duration of hospitalization, complications, mortality, and recurrence of disease. Of the 72 patients (34 males and 38 females, mean age 77 years) 47% were nursing home residents. Pre-hospitalization antibiotic treatment was given to 91.4% for infections of the upper respiratory tract (45%) and urinary tract (45%). The most common antibiotics were cephalosporin (64%), penicillins (42%) and quinolones (28%). Sixty-four percent of the patients were treated with more than one antibiotic, 26% of patients received anti-acid therapy and 36% had been fed with a nasogastric tube. On admission, leukocytosis was found in 79% of patients, &gt; 20,000/mm3 in half of them; 60% were anemic, 60% had elevated erythrocyte sedimentation rate, and 78% had hypoalbuminemia. Treatment consisted of metronidazole (41%) or a combination of metronidazole and vancomycin (56%). Overall, 31% of patients recovered without complications, 29% died within 30 days of hospitalization, and 24% were re-hospitalized due to recurrence of PMC. The most common antibiotics implicated in PMC are cephalosporin, penicillins and quinolones. The disease is associated with high mortality and recurrence rates.</abstract><cop>Israel</cop><pmid>15115256</pmid><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1565-1088
ispartof The Israel Medical Association journal, 2004-04, Vol.6 (4), p.201-204
issn 1565-1088
language eng
recordid cdi_pubmed_primary_15115256
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adult
Aged
Anti-Bacterial Agents - adverse effects
Enterocolitis, Pseudomembranous - chemically induced
Enterocolitis, Pseudomembranous - diagnosis
Enterocolitis, Pseudomembranous - drug therapy
Female
Humans
Male
Metronidazole - therapeutic use
Middle Aged
Retrospective Studies
title Clinical manifestations and outcome of pseudomembranous colitis in an elderly population in Israel
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T09%3A53%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_igdc_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20manifestations%20and%20outcome%20of%20pseudomembranous%20colitis%20in%20an%20elderly%20population%20in%20Israel&rft.jtitle=The%20Israel%20Medical%20Association%20journal&rft.au=Moshkowitz,%20Menachem&rft.date=2004-04-01&rft.volume=6&rft.issue=4&rft.spage=201&rft.epage=204&rft.pages=201-204&rft.issn=1565-1088&rft_id=info:doi/&rft_dat=%3Cpubmed_igdc_%3E15115256%3C/pubmed_igdc_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15115256&rfr_iscdi=true